Assessing Psoriatic Arthritis Research For the Future

Philip Mease shared that he and his team are in the midst of preparing the content of the studies for publication to ensure continued education about psoriatic arthritis treatment. Mease concluded, "We're very excited about this new data because this a patient population that historically has had few treatments at least until the anti-TNF medicines came along, and now we're finding that for patients who don't respond adequately to the anti-TNFs, it's important to have new mechanisms of action for treating this very important population of rheumatology patients."